The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk NAFLD in primary care.

Pimsiri Sripongpun W Ray Kim Ajitha MannalitharaVivek CharuAnna VidovszkySteven AschManisha DesaiSun H Kim Allison J Kwong

Published in: Hepatology (Baltimore, Md.) (2022)

The SAFE score, which uses widely available variables to estimate liver fibrosis in patients diagnosed with NAFLD, may be used in primary care to recognize low-risk NAFLD.

Keyphrases

primary care
liver fibrosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
insulin resistance
high fat diet
general practice
metabolic syndrome
adipose tissue